TriangleNCT02761187 · OUTCOME
Number of Participants With ECOG (Eastern Cooperative Oncology Group) Performance Status
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- At Baseline
What was measured
ECOG-PS measured on-therapy (time between first dose and last dose date with a 30-day lag) assessed participant's performance status on 6 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (\>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. The line of Therapy was determined at study entry.
Analysis population: All Enrolled Population included all participants who signed informed consent. Overall number of participants analyzed is the number of participants available for analysis.
Groups in this outcome
NDMM
Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
RRMM
Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
| Group | Source count |
|---|---|
| NDMM | 1761 |
| RRMM | 1440 |
Reported measurements
Grade 0
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 714 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 710 | Not reported | Not reported | Not reported | Not reported |
Grade 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 727 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 559 | Not reported | Not reported | Not reported | Not reported |
Grade 2
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 171 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 113 | Not reported | Not reported | Not reported | Not reported |
Grade 3
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 61 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 22 | Not reported | Not reported | Not reported | Not reported |
Grade 4
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 13 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 2 | Not reported | Not reported | Not reported | Not reported |
Missing
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 75 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 34 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- OG000
- value
- 714
- group Id
- OG001
- value
- 710
- title
- Grade 0
- categories
- measurements
- group Id
- OG000
- value
- 727
- group Id
- OG001
- value
- 559
- title
- Grade 1
- categories
- measurements
- group Id
- OG000
- value
- 171
- group Id
- OG001
- value
- 113
- title
- Grade 2
- categories
- measurements
- group Id
- OG000
- value
- 61
- group Id
- OG001
- value
- 22
- title
- Grade 3
- categories
- measurements
- group Id
- OG000
- value
- 13
- group Id
- OG001
- value
- 2
- title
- Grade 4
- categories
- measurements
- group Id
- OG000
- value
- 75
- group Id
- OG001
- value
- 34
- title
- Missing
- denoms
- counts
- group Id
- OG000
- value
- 1761
- group Id
- OG001
- value
- 1440
- units
- Participants
- description
- ECOG-PS measured on-therapy (time between first dose and last dose date with a 30-day lag) assessed participant's performance status on 6 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (\>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. The line of Therapy was determined at study entry.
- groups
- description
- Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
- id
- OG000
- title
- NDMM
- description
- Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
- id
- OG001
- title
- RRMM
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- All Enrolled Population included all participants who signed informed consent. Overall number of participants analyzed is the number of participants available for analysis.
- reporting Status
- POSTED
- time Frame
- At Baseline
- title
- Number of Participants With ECOG (Eastern Cooperative Oncology Group) Performance Status
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice